Madrigal Pharmaceuticals (MDGL) SEC Filings & 10K Form

$194.38
-10.27 (-5.02%)
(As of 04/25/2024 ET)

Recent Madrigal Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/10/2024
7:50 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
7:53 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
7:50 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
7:50 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:41 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:44 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:47 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:22 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:21 PM
BAKER BROS. ADVISORS LP (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:28 PM
BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
03/21/2024
3:30 PM
Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2024
3:11 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:10 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:01 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
5:32 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
1:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
8:21 AM
Avoro Capital Advisors LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
4:55 PM
JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
01/25/2024
5:04 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:50 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:54 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
10:13 AM
Madrigal Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
12:52 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
12:39 PM
Howarth Alex G. (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
12:45 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
12:46 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
12:47 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
12:45 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
3:30 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
5:09 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
5:10 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:30 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:25 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:30 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:30 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:02 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:14 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:15 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:24 PM
BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
11/15/2023
4:12 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.
11/15/2023
4:13 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
3:39 PM
Madrigal Pharmaceuticals (Subject)
PAULSON & CO. INC. (Filed by)
Form SC 13G
11/06/2023
7:31 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
5:10 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2023
12:05 PM
JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
10/05/2023
3:36 PM
BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
10/05/2023
3:27 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
4:15 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
4:10 PM
Madrigal Pharmaceuticals (Filer)
Form 424B5
09/28/2023
3:01 PM
Madrigal Pharmaceuticals (Filer)
Form 424B5
09/25/2023
3:02 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:31 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
3:35 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/13/2023
3:41 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:25 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
3:30 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
3:31 PM
Madrigal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/08/2023
3:36 PM
JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G
08/08/2023
4:16 PM
BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
08/08/2023
8:19 AM
Madrigal Pharmaceuticals (Filer)
Form 424B3
08/08/2023
7:00 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
5:50 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2023
7:00 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
1:21 PM
Gollust Keith R (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
7:00 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
6:58 PM
Gollust Keith R (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2023
7:04 PM
Gollust Keith R (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2023
5:46 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
5:47 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:10 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
5:17 AM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2023
5:19 AM
Cheong Raymond (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2023
8:02 AM
Madrigal Pharmaceuticals (Filer)
Form 424B5
05/09/2023
7:00 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2023
7:16 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2023
5:51 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2023
8:11 AM
Madrigal Pharmaceuticals (Filer)
Form DEF 14A
05/01/2023
8:15 AM
Madrigal Pharmaceuticals (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MDGL) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners